Cas No.: | 339177-26-3 |
pH value: | Corresponds to reference standard: PASS |
Non-reduced CE-SDS: | 98.1% |
SEC-HPLC: | 99.2% |
Isoelectric Point: | Corresponds to reference standard |
Bacterial Endotoxins Test: | <1 EU/ml |
Exogenous Residual DNA: | <1 pg/mg |
Residual protein A: | <1 ng/mg |
Biological Activity: | Compared with standard, the range ofbiological activity is 115% |
Osmolality: | Corresponds to reference standard: PASS |
Peptide mapping: | Corresponds to reference standard: PASS |
N-terminal sequence: | Corresponds to reference standard:PASS |
Description: | Panitumumab, formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans). |
References: | [1]. Yu Jo Chua, et al. Panitumumab. Drugs Today (Barc). 2006 Nov;42(11):711-9. |